Dave Lennon's CEO ad­ven­ture goes from pre­clin­i­cal to com­mer­cial; GSK vet em­barks on new Odyssey with Gary Glick

Af­ter step­ping in­to the CEO post for the first time about two years ago, tak­ing over the helm of “tis­sue ther­a­peu­tics” start­up Satel­lite Bio, Dave Lennon is ready to take on his next chal­lenge in the C-suite.

On Mon­day, he trad­ed hats from the pre­clin­i­cal Boston start­up for the com­mer­cial-stage Los An­ge­les drug­mak­er Aa­di Bio­science. About a year and a half in­to the launch of its ul­tra-rare sar­co­ma drug Fyarro, Aa­di has big la­bel ex­pan­sion plans.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER